Clinical course of four patients receiving the experimental antiviral agent fialuridine for the treatment of chronic hepatitis B infection

Transplant Proc. 1995 Feb;27(1):1219-21.
No abstract available

MeSH terms

  • Antiviral Agents / therapeutic use*
  • Antiviral Agents / toxicity*
  • Arabinofuranosyluracil / analogs & derivatives*
  • Arabinofuranosyluracil / therapeutic use
  • Arabinofuranosyluracil / toxicity
  • Clinical Trials, Phase I as Topic
  • Clinical Trials, Phase II as Topic
  • Hepatitis B / blood
  • Hepatitis B / drug therapy*
  • Humans
  • Lactates / blood
  • Liver Transplantation
  • Randomized Controlled Trials as Topic

Substances

  • Antiviral Agents
  • Lactates
  • Arabinofuranosyluracil
  • fialuridine